| More

Patients΄ complications during classic hemodialysis session

Views: 107 Downloads: 1158
Georgios Georgiadis, Olga Kadda
Georgios Georgiadis, Olga Kadda

Abstract


Introduction: Patients with end stage renal disease, who are submitted to chronic hemodialysis (HD) therapy, exhibit a variety of complications, leading to increased possibility of interruption of the current therapy session, possible withdrawal of the future HD sessions and eventually, poor outcome for these patients’ health.

Aim: The aim of the present study was to explore complications and symptoms of patients under classical hemodialysis treatment, during the session of therapy.

Methodology: The methodology that was followed included the review of the Greek and international literature of the last ten years in the databases (Pubmed, Google Scholar, medline). Key words such as: «end stage renal disease», «HD complications», «HD symptoms», «intradialytic hypotension», were used.

Results: Despite the extensive knowledge and experience surrounding the treatment of classical hemodialysis, patients continue to experience a variety of symptoms during the hemodialysis session. The rates of many complications like hypotension, hypertension, nausea and vomiting, etc. continue to be high in many hemodialysis units in the world. Also according to the literature patients with high risk medical history, especially male patients, experience the most complications.

Conclusions: Although developed technology in combination with specialized nurses provide a better profile of HD session therapy, plenty of complications and symptoms continue to exist, worsening the quality of the HD therapy and the quality of life of the patients submitted to classical HD treatment.

Keywords


End stage renal disease, HD complications, intradialytic hypotension, HD symptoms

Full Text:

PDF

References


Γριβέας Ι. Χρόνια νεφρική νόσoς: από την πρωτoβάθμια στη δευτερoβάθμια φρoντίδα. Ελληνική Νεφρoλoγία 2014; 26 (4): 303 – 309.

National Kidney Foundation. Glomerular Filtration Rate (Gfr). Ανάκτηση 2 Ιανουαρίου 2017 από: https://www.kidney.org/atoz/content/gfr.

Τουλιά Τ, Κουτσοπούλου Β. Ποιότητα ζωής αιμοκαθαρόμενων ασθενών. Περιεγχειρητικη Νοσηλευτική 2015; 4(1):10-18.

Ιωαννίδης Γ, Παπαδάκη Ο. Στατιστικά και επιδημιολογικά δεδομένα θεραπείας υποκατάστασης νεφρικής λειτουργίας στην Ελλάδα, 2000-2011. Έκθεση δεδομένων της 12ετούς λειτουργίας του Εθνικού Αρχείου Καταγραφής Νεφροπαθών. Ελληνική Νεφρολογία 2013; 25 (4): 266 – 284.

Gayle F, Soyibo AK, Gilbert DT, Manzanares J, Barton EN, Quality of life in end stage renal disease: A multicentre comparative study. West Indian Med J 2009;58(3):235−242.

Agarwal R. How can we prevent intradialytic hypotension. Curr Opin Nephrol Hypertens 2012; 21: 593–599.

Hering D, Esler MD, Schlaich MP. Chronic kidney disease: role of sympathetic nervous system activation and potential benefits of renal denervation. Journal of EuroPCR in Collaboration With the Working Group on Interventional Cardiology of the European Society of Cardiology 2013;9:127135.

Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012; 60: 599-606.

Sarafidis PA, Sharpe CC, Wood E, και συν. Prevalence, patterns of treatment, and control of hypertension in predialysis patients with chronic kidney disease. Nephron Clin Pract 2012; 120: 147-155.

Inrig J, Patel N, Toto R. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 2009; 54: 881-890.

Park J, Campese VM, Nobakht N, και συν. Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J Appl Physiol 2008; 105: 1873-1876.

Prasad VS, Palaniswamy C, Frishman WH. Endothelin as a clinical target in the treatment of systemic hypertension. Cardiol Rev 2009; 17: 181-191.

Τσίκληρας Ν.Χ, Μαδεμτζόγλου Σ, Μπαλάσκας Η.Β. Προτυποποίηση νατρίου και υπερδιήθησης: η επίδραση ενός εναλλακτικού μοντέλου στην υπόταση της ΑΜΚ. Ελληνική Νεφρολογία 2014; 26 (3): 225 – 232.

Chia-Ter C, Jenq-Wen H, Chung-Jen Y. Intradialytic Hypotension and Cardiac Remodeling: A Vicious Cycle. BioMed Research International 2015: 1-7.

Foley RN, Gilbertson DT, Murray T, Collins AJ. Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 2011; 365:1099–1107.

Drechsler C, Krane V, Winkler K, Dekker FW, Wanner C. Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction and mortality in hemodialysis patients. Kidney Int 2009; 76: 567-575.

Lee T, Ullah A, Allon M, Succop P, ElKhalib M, Munda R, Roy-Chaudhury P. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Nephrol 2011; 6 (3): 575-581.

McCann M, Einarsdottir H, Van Waeleghem JP. Vascular Access Management II: AVF/AVG Cannulation Techniques and Complications. Journal of Renal Care 2009; 35 (2): 90-98.

Jalal DI, Chonchol M, Targher G: Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 2010; 36:34–40.

Rodger M, Ramsay T, MacKinnon M, Westphal M, Wells P, McCornick B, Knoll G. Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 60:427–434.

Lewis EF, Pfeffer MA, Feng A, et al: Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol 2011; 6: 845–855.

Yoon J, Thapa S, Chow RD, Jaar BG. Hemolysis as a rare but potentially life-threatening complication of hemodialysis: A case report. BMC Res Notes 2014; 7: 475-477.

Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Szebeni J, Weiss G. Hypersensitivity reactions to intravenous iron: Guidance for risk minimization and management. Haematologica 2014; 99:1671–1676.

Sayeed K, Murdakes C, Spec A, Gashti C. Anaphylactic shock at the beginning of hemodialysis. Semin Dial 2016; 29: 81–84.

Wong B, Zimmerman D, Reintjes F, Courtney M, Klarenbach S, Dowling G, Pauly RP. Procedure-related serious adverse events among home hemodialysis patients: A quality assurance perspective. Am J Kidney Dis 2014; 63: 251–258.

Pscherer S, Heemann U, Frank H. Effect of renin-angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance. Diabetes Care 2010; 33: 914-919.

Drechsler C, Krane V, Winkler K, Dekker FW, Wanner C. Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction and mortality in hemodialysis patients. Kidney Int 2009; 76: 567-575.

Titze J. Water-free sodium accumulation. Semin Dial 2009; 22: 253-255.

Beduschi GC, Telini SR, Caramori JCT, Martin LC, Barretti P. Effect of dialysate sodium reduction on body water volume, blood pressure, and inflammatory markers in hemodialysis patients - a prospective randomized controlled study. Ren Fail 2013; 35: 742-747.

Caplin B, Kumar S, Davenport A. Patients’ perspective of haemodialysis-associated symptoms. Nephrol Dial Transplant. 2011; 26(8):2656–2663.

Weisbord S.D. Patient-Centered Dialysis Care: Depression, Pain, and Quality of Life. Patient-Centered Dialysis Care 2016: 158-164.

Lopes GB, Nogueira FC, de Souza MR, και συν. Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form. Qual Life Res. 2012; 21:603-12.

Tamadon MR, Beladi Mousavi SS. Erythropoietin: a Review on Current Knowledge and New Concepts. J Ren Inj Prev 2013; 2(4):119-21.

Kistler BM, Fitschen PJ, Ikizler TA, Wilund KR. Rethinking the Restriction on Nutrition During Hemodialysis Treatment. J Ren Nutr 2015; 25 (2): 81-87.

Meredith D.J, Pugh C.W, Sutherland S, Tarassenko L, Birks J. The relationship between symptoms and blood pressure during maintenance hemodialysis. Hemodialysis International 2015; 19:543–552.


Refbacks

  • There are currently no refbacks.


Health and Research Journal